Way to go Kayla, so well-deserved!
Feeling incredibly thankful to be awarded an NIH F30 Fellowship to continue my PhD work in cancer immunology. And grateful for my PI @xrtcell and my amazing lab for their support!View quoted post on X
Anusha Kalbasi
@xrtcell
cancer immunology - sarcoma - melanoma - radiation oncology - kalbasilab.org @stanford
417 Following 712 Followers 282 Posts
Latest posts 5
If you haven’t REAP’d, have you really lived?
Autoantibodies cause autoimmune disease, shape infection outcomes, and alter cancer immunotherapy. But what role might they play in neuropsychiatric disease? In our new preprint, Katlyn Nemani and @JillianRJaycox take on this question in schizophrenia. 🧵
biorxiv.org/content/10.648…View quoted post on X
Radiation is a powerful anti-cancer agent, but I considered it a weak immunomodulator. Our new study @CD_AACR changed my mind: in the right context, RT can incite potent systemic immune responses in patients (even rare irAEs). Which context? brnw.ch/21x1b6E
A 🧵 /1
A 🧵 /1
aacrjournals.org Neoadjuvant BO-112 and Hypofractionated Radiation Therapy with or without Nivolumab in Soft-Tissue... Intratumoral BO-112 (nanoplexed poly I:C) with hypofractionated radiotherapy engages myeloid cells to promote T cell–mediated immunity across preclinical models and a phase I trial in sarcoma. thanks @JoeFraietta and Janna for having me on!
In our latest episode of #ImmunoLogic, the hosts spoke with Anusha Kalbasi, MD (@xrtcell, @stanford) about his research on IL-9 and CAR-T
#Oncology #Immunotherapy @PennMedicine @JoeFraietta
Watch now:
hubs.li/Q03WB7TD0View quoted post on X
What if nature already has the optimal cytokine solution for T cell therapy, but we just haven’t found it yet? Check out our paper out today in Immunity on IL-9 as a naturally orthogonal cytokine ideally tuned for T cell therapy authors.elsevier.com/sd/article/S10…
1/9
1/9